1. Ichiyama, Kenji, Long, Jia, Kobayashi, Yusuke, Georgopoulos, Katia, Sakaguchi, Shimon. 2024. Transcription factor Ikzf1 associates with Foxp3 to repress gene expression in Treg cells and limit autoimmunity and anti-tumor immunity. In Immunity, 57, 2043-2060.e10. doi:10.1016/j.immuni.2024.07.010. https://pubmed.ncbi.nlm.nih.gov/39111316/
2. Vervoort, Britt M T, Butler, Miriam, Grünewald, Kari J T, Van der Meer, Laurens T, Van Leeuwen, Frank N. 2024. IKZF1 gene deletions drive resistance to cytarabine in B-cell precursor acute lymphoblastic leukemia. In Haematologica, 109, 3904-3917. doi:10.3324/haematol.2023.284357. https://pubmed.ncbi.nlm.nih.gov/38841778/
3. Mullighan, Charles G, Su, Xiaoping, Zhang, Jinghui, Willman, Cheryl L, Downing, James R. 2009. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. In The New England journal of medicine, 360, 470-80. doi:10.1056/NEJMoa0808253. https://pubmed.ncbi.nlm.nih.gov/19129520/
4. Brodie, Seth A, Khincha, Payal P, Giri, Neelam, Alter, Blanche P, Savage, Sharon A. 2021. Pathogenic germline IKZF1 variant alters hematopoietic gene expression profiles. In Cold Spring Harbor molecular case studies, 7, . doi:10.1101/mcs.a006015. https://pubmed.ncbi.nlm.nih.gov/34162668/